Be the first person to write a business review for Navilyst Medical, Inc.

Neoprobe makes products for the diagnosis and treatment of cancer, such as lymphatic mapping instruments (including the neo2000) that help surgeons identify trends about the spread of cancer in a patient. Subsidiary Cardiosonix markets non-invasive blood flow measurement devices under the Quantix brand. Neoprobe has additional products under development including procedural tracing agent Lymphoseek to be used in lymphatic mapping and handheld radiation probe RIGScan to locate tumors. The company is also working on an activated cellular therapy technology to treat cancers and viral and autoimmune diseases. The procedure activates certain lymph nodes to boost a patient's immune system.

Nipro Diagnostics,Inc. makes blood glucose monitoring systems and disposable supplies for diabetics, which it sells through retail pharmacies, mass merchandisers, managed care companies, mail service providers, and distributors around the globe. Nipro Diagnostics markets its testing systems and blood monitors through those distribution channels in two ways, under its own brand names -- including Sidekick, TrueTrack Smart System, TRUEread, and Prestige IQ -- and through co-branded partnerships. The company is a wholly owned subsidiary of Japanese medical device maker Nipro.

Nobel Biocare can fix you up with restorative dental implants, crowns, or bridgework when your natural teeth fail you. The company also makes dental prosthetics (dentures) and has products to plug up any small gaps between teeth for purely aesthetic reasons. Its brands include Brånemark, NobelDirect, and Procera (which it rebranded as NobelProcera in 2009). Based in Switzerland, the company has production facilities in Sweden, US, Japan, and Israel. It has a direct sales presence in more than 35 countries and also sells through distributors, giving it a global reach.

NIMS(Non-Invasive Monitoring Systems, Inc.) has developed a moving bed-style device that is intended to improve circulation and joint mobility, and possibly to relieve minor aches and pains. Originally tagged as AT-101, the device was sold in Japan and the US until the FDA required the company to get regulatory approval for it. NIMS halted sales and marketing efforts on AT-101 and is seeking FDA approval for a similar but less costly device known as the Exer-Rest, intended for home and clinic use.

Noninvasive Medical Technologies helps physicians provide gentler health care. The company manufactures noninvasive hemodynamic monitors that measure blood flow, heart rate, stroke volume, and cardiac output. Its IQ2 is used to assess and evaluate cardiac function. The ZOE device determines if a patient is retaining fluids or is dehydrated without drawing blood. By quickly assessing fluid status, doctors can better treat those at risk for severe or recurring dehydration such as hypertension and heart failure patients and athletes. The company also sells ICG sensors (to obtain hemodynamic data) and electrodes used with its devices. NMT has a supplier agreement with Royal Philips Electronic for its ZOE monitor.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.